Vivo Capital, LLC Purchases and Sells in Q2 2025

Vivo Capital, LLC

$472 Million
Q2 2025

Top Buys

Incresed Positions

5 operations

Stock	Shares change	Price Range	Shares Held	Trade History
ORIC	1.05M + 50.28%	$4.26 - $10.55 $4.46M - $11M	3.13M $31.7M
AKRO	234K + 116.08%	$34.04 - $56.28 $7.95M - $13.1M	435K $23.2M
CMPX	2.49M + 69.95%	$1.46 - $2.69 $3.63M - $6.69M	6.04M $15.7M
TRVI	1M + 28.67%	$5.28 - $7.06 $5.28M - $7.06M	4.49M $24.5M
Cidara Therapeutics, Inc.	627K + 91.65%	N/A	1.31M $0

New Holdings

7 operations

Stock	Shares change	Price Range	Shares Held	Trade History
CTMX	5.77M New	$0.43 - $2.99 $2.48M - $17.2M	5.77M $13.1M
TNGX	600K New	$1.1 - $5.47 $660K - $3.28M	600K $3.07M
Bolt Therapeutics Inc	176K New	N/A	176K $0
DBV Technologies SA	1.05M New	N/A	1.05M $0
Praxis Precision Medicines	168K New	N/A	168K $0
Sinovac Biotech Ltd.	5.9M New	N/A	5.9M $0

Top Sells

Reduced Positions

4 operations

Stock	Shares change	Price Range	Shares Held	Trade History
DCTH	-181K - 24.08%	$10.39 - $18.1 $1.88M - $3.27M	570K $7.75M
Instil Bio Inc	-293K - 50.0%	N/A	293K $0
Soleno Therapeutics Inc	-500K - 11.22%	N/A	3.96M $0
VRNA	-45.4K - 3.15%	$53.9 - $98.68 $2.44M - $4.48M	1.39M $132M

Activity Summary All Purchases 12 New Holdings 7 Increased Positions 5 All Sells 4 Reductions 4 Sold out 0 Calls 0 Puts 0

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.